Monday, December 08, 2025 | 05:23 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Mixing Covaxin and Covishield induces four times more antibodies: Study

The Spike-protein neutralizing antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid
premium

AIG Hospitals has shared the data from the study with the ICMR to be considered as a reference study while deciding on the prevention doses starting January 10

Sohini Das Mumbai
It is safe to mix Covishield (AstraZeneca vaccine) and Covaxin (Bharat Biotech vaccine) and mixing induces four times more antibodies than giving the same vaccine dose, showed a study conducted by a Hyderabad-based private hospital. The hospital has shared its findings with India’s apex health research body the Indian Council of Medical Research (ICMR).

A total of 330 healthy volunteers — who were not vaccinated and had no history of Covid-19 infection — were screened for SARS-CoV-2 antibodies for the study conducted by AIG Hos­pitals, along with researchers from the Asian Healthcare Foundation.

Of them, 44 (13 per cent) participants were found